Bapineuzumab Effects On Cerebrospinal Fluid Biomarkers In Alzheimer’s Patients

Editors ChoiceAcademic JournalMain Category: Alzheimers / Dementia
Also Included In: Neurology / Neuroscience
Article Date: 05 Apr 2012 5:00 PDT

email to a crony   printer accessible   opinions  

! rate article

Patient / Public:
1 (1 votes)
Healthcare Prof:
4 (1 votes)
A investigate published Online First by Archives of Neurology, a JAMA Network publication, reveals that patients with amiable to assuage Alzheimer illness who perceived immunotherapy with a antibody bapineuzumab showed decreases in a cerebrospinal liquid biomarker. According to a researchers a formula might prove successive effects on a degenerative process.

According to credentials information in a article, Alzheimer illness (AD) is a on-going neurodegenerative disease. Amongst other characteristics, AD patients have deposits of extracellular β-amyloid (Aβ) plaques and intraneuronal neurofibrillary tangles, together with decreases in cerebrospinal liquid (CSF) Aβ and aloft level...